Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

11β-Hydroxysteroid dehydrogenase Type 1 activity in lean and obese males with Type 2 diabetes mellitus

Tools
- Tools
+ Tools

Valsamakis, Georgios, Anwar, A., Tomlinson, J. W., Shackleton, C. H. L., McTernan, P. G. (Philip G.), Chetty, R., Wood, P. J., Banerjee, A. K., Holder, G., Barnett, A. H., Stewart, P. M. and Kumar, Sudhesh (2004) 11β-Hydroxysteroid dehydrogenase Type 1 activity in lean and obese males with Type 2 diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism, Volume 89 (Number 9). pp. 4755-4761. doi:10.1210/jc.2003-032240

Research output not available from this repository, contact author.
Official URL: http://dx.doi.org/10.1210/jc.2003-032240

Request Changes to record.

Abstract

Glucocorticoids play an important role in the pathogenesis of obesity and insulin resistance. Impaired conversion of cortisone (E) to cortisol (F) by the type 1 isoenzyme of 11β-hydroxysteroid dehydrogenase (11β-HSD) in obesity may represent a protective mechanism preventing ongoing weight gain and glucose intolerance. We have studied glucocorticoid metabolism in 33 male subjects with type 2 diabetes mellitus [age, 44.2 ± 13 yr; body mass index (BMI), 31.1 ± 7.5 kg/m2 (mean ± sd)] and 38 normal controls (age, 41.4 ± 14 yr; BMI, 38.2 ± 12.8 kg/m2).
Circulating F:E ratios were elevated in the diabetic group and correlated with serum cholesterol and homeostasis model assessment-S. There was no difference in 11β-HSD1 activity between diabetic subjects and controls. In addition, 11β-HSD1 activity was unaffected by BMI in diabetic subjects. However, in control subjects, increasing BMI was associated with a reduction in the urinary tetrahydrocortisol+5α-tetrahydrocortisol:tetrahydrocortisone ratio (P < 0.05) indicative of impaired 11β-HSD1 activity. The degree of inhibition correlated tightly with visceral fat mass. Changes in 11β-HSD1 activity could not be explained by circulating levels of adipocytokines.
Impaired E to F metabolism in obesity may help preserve insulin sensitivity and prevent diabetes mellitus. Failure to down-regulate 11β-HSD1 activity in patients with diabetes may potentiate dyslipidemia, insulin resistance, and obesity. Inhibition of 11β-HSD1 may therefore represent a therapeutic strategy in patients with type 2 diabetes mellitus and obesity

Item Type: Journal Article
Divisions: Faculty of Medicine > Warwick Medical School
Journal or Publication Title: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
ISSN: 0021-972X
Official Date: 2004
Dates:
DateEvent
2004Published
Volume: Volume 89
Number: Number 9
Page Range: pp. 4755-4761
DOI: 10.1210/jc.2003-032240
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us